Lupin has entered into a partnership with Shenzhen Foncoo Pharmaceutical Company (Foncoo). This is Lupin’s first partnership arrangement in China and reinforces its commitment to bringing high quality generic and complex generic medicines to patients around the world.
With China’s growing commitment to affordable and accessible healthcare, Lupin is committed to serving the healthcare needs of the Chinese population by providing high quality generic and complex generic products.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.
